Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study (Q40436942)

20 September 2017

title

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study (English)

1 reference

20 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Markus Ball

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alan F List

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Qing Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Zhenjun Ma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

YuLong Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sean J Yoder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Maria E Balasis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tania E Mesa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

David A Sallman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jeffrey E Lancet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Rami S Komrokji

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Howard L McLeod

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Melissa Alsina

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Rachid Baz

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Kenneth H Shain

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dana E Rollison

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Eric Padron

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

2 December 2016

1 reference

Lancet Oncology Commission

20 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

112-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27927582%20AND%20SRC:MED&resulttype=core&format=json

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Therapy-related myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Implementing personalized medicine in a cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

The Sequence Alignment/Map format and SAMtools

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

The variant call format and VCFtools

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Clinical and biological implications of driver mutations in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930627-1

7 January 2021

Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27927582

12 December 2020

inferred from PubMed ID database lookup

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27927582

12 December 2020